Long Terminal Repeat CRISPR-CAR-Coupled “Universal” T Cells Mediate Potent Anti-leukemic Effects-Reference-Cited by-同舟云学术

Long Terminal Repeat CRISPR-CAR-Coupled “Universal” T Cells Mediate Potent Anti-leukemic Effects

Published:2018-05 Issue:5 Volume:26 Page:1215-1227
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Georgiadis Christos,Preece Roland,Nickolay Lauren,Etuk Aniekan,Petrova Anastasia,Ladon Dariusz,Danyi Alexandra,Humphryes-Kirilov Neil,Ajetunmobi Ayokunmi,Kim Daesik,Kim Jin-Soo,Qasim Waseem

Funder

National Institute of Health Research

NIHR Blood and Transplant Research Unit

Great Ormond Street Biomedical Research Centre

Children with Cancer

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference36 articles.

1. Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective;Rivière;Mol. Ther.,2017

2. A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR;Torikai;Blood,2012

3. Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer;Provasi;Nat. Med.,2012

4. Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells;Qasim;Sci. Transl. Med.,2017

5. Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies;Poirot;Cancer Res.,2015

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapy;Frontiers in Immunology;2024-08-30

2. CAR-T Therapy in HIV: Pioneering Advances and Navigating Challenges;Infectious Diseases & Immunity;2024-07-25

3. Non-viral delivery of RNA for therapeutic T cell engineering;Advanced Drug Delivery Reviews;2024-05

4. Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies;Molecular Cancer;2024-04-05

5. CAR‐T‐cell products in solid tumors: Progress, challenges, and strategies;Interdisciplinary Medicine;2024-04